Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-1282-2024 — LVP software of the Ivenix Infusion System (IIS), LVP-SW-0004

U.S. FDA — Device Enforcement · United States · 2022-09-16 · Class II

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-1282-2024
Date of alert
2022-09-16
Country / jurisdiction
United States
Risk level
Class II
Risk type
recall
Brand
Fresenius Kabi USA, LLC
Product category
device
Product type
Devices
Barcode (EAN/GTIN)
00811505030122
Reported risk: Retroactively reported correction from 2022: A software defect may cause an incorrect (Fail-Stop) Alarm when an administration set is loaded with an upstream occlusion present, resulting in a non-recoverable (Fail-Stop) Pump Problem alarm. This may lead to delay of therapy, and patient may experience from no to minimal to serious harm. This issue was resolved in all fielded product in software version 5.2.1, which was installed in September 2022.
Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.